Low-density lipoprotein protects Vibrio vulnificus-induced lethality through blocking lipopolysaccharide action

Experimental and Molecular Medicine

Volumn 39, Issue 5, 2007, Pages 673-678

  Park, Kwang Hyun ^a,b   Kim, Jong Suk ^b   Lee, Young Rae ^b   Moon, Young Jae ^b   Hur, Hyun ^b   Choi, Yun Hee ^b   Kim, Cheon Hyeon ^b   Kim, Uh Hyun ^b   Song, Eun Kyung ^b   Yoo, Wan Hee ^b   Lee, Chang Seop ^b   Kim, Byeong Soo ^c   Lee, Sung Ho ^c   Ryu, Phil Youl ^d   Han, Myung Kwan ^b  

^a Wonkwang University   (South Korea)

^b Chonbuk National University Medical School   (South Korea)

^c Kongju National University   (South Korea)

^d Chonnam National University Medical School   (South Korea)

Author keywords

Endotoxemia; Lipopolysaccharides; Lipoproteins, LDL; Vibrio vulnificus, vvP protein, Vibrio vulnificus

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CYTOLYSIN; ENDOTOXIN; EXOTOXIN; LOW DENSITY LIPOPROTEIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GRAM NEGATIVE INFECTION; HUMAN; MALE; MOUSE; NONHUMAN; PROTEIN FUNCTION; VIBRIO VULNIFICUS; WILD TYPE;

BACTERIA (MICROORGANISMS); MUS; VIBRIO VULNIFICUS;

EID: 36148989855     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2007.73     Document Type: Article

References (27)

1. Bahrani KF, Oliver JD. Electrophoretic analysis of lipopolysaccharide isolated from opaque and translucent colony variants of Vibrio vulnificus using various extraction methods. Microbios 1991;66:83-93
2. Barlage S, Frohlich D, Bottcher A, Jauhiainen M, Muller HP, Noetzel F, Rothe G, Schutt C, Linke RP, Lackner KJ, Ehnholm C, Schmitz G. ApoE-containing high density lipoproteins and phospholipid transfer protein activity increase in patients with a systemic inflammatory response. J Lipid Res 2001;42:281-90
3. Beigneux AP, Moser AH, Shigenaga JK, Grunfeld C, Feingold KR. The acute phase response is associated with retinoid X receptor repression in rodent liver. J Biol Chem 2000;275:16390-9
4. Bhakdi S, Tranum-Jensen J, Utermann G, Fussle R. Binding and partial inactivation of Staphylococcus aureus α-toxin by human plasma low density lipoprotein. J Biol Chem 1983;258:5899-904
5. Canturk NZ, Canturk Z, Okay E, Yirmibesoglu O, Eraldemir B. Risk of nosocomial infections and effects of total cholesterol, HDL cholesterol in surgical patients. Clin Nutr 2002;21:431-6
6. Carpentier YA, Scruel O. Changes in the concentration and composition of plasma lipoproteins during the acute phase response. Curr Opin Clin Nutr Metab Care 2002;5:153-8
7. Chien JY, Jerng JS, Yu CJ, Yang PC. Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis. Crit Care Med 2005;33:1688-93
8. Delgado-Rodriguez M, Medina-Cuadros M, Gomez-Ortega A, Martinez-Gallego G, Mariscal-Ortiz M, Martinez-Gonzalez MA, Sillero-Arenas M. Cholesterol and serum albumin levels as predictors of cross infection, death, and length of hospital stay. Arch Surg 2002;137:805-12
9. Fraunberger P, Schaefer S, Werdan K, Walli AK, Seidel D. Reduction of circulating cholesterol and apolipoprotein levels during sepsis. Clin Chem Lab Med 1999;37:357-62
10. Gray LD, Kreger AS. Detection of anti-Vibrio vulnificus cytolysin antibodies in sera from mice and a human surviving V. vulnificus disease. Infect Immun 1986;51:964-5
11. Khovidhunkit W, Kim MS, Memon RA, Shigenaga JK, Moser AH, Feingold KR, Grunfeld C. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res 2004;45:1169-96
12. Kim BS, Kim JS. Cholesterol induce oligomerization of Vibrio vulnificus cytolysin specifically. Exp Mol Med 2002;34:239-42
13. Kitchens RL, Thompson PA, Munford RS, O'Keefe GE. Acute inflammation and infection maintain circulating phospholipid levels and enhance lipopolysaccharide binding to plasma lipoproteins. J Lipid Res 2003;44:2339-48
14. Koo BS, Lee DS, Yang JY, Kang MK, Sohn HS, Park JW. Lipoprotein lipase-mediated uptake of glycated LDL. J Biochem Mol Biol 2000;33:148-54
15. Kreger AS, Kothary MH, Gray LD. Cytolytic toxins of Vibrio vulnificus and Vibrio damsela. Methods Enzymol 1988;165:176-89
16. Lee YR, Park KH, Lin ZZ, Kho YJ, Park JW, Rho HW, Koo BS, Kim HR, Song EK, Yu HN, Han MK, Lee SO, Jhee EC, Kim JS. A calcium-calmodulin antagonist blocks experimental Vibrio vulnificus cytolysin-induced lethality in an experimental mouse model. Infect Immun 2004;72:6157-9
17. Liu D, Zeng BX, Zhang SH, Yao SL. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor γ, reduces pulmonary inflammatory response in a rat model of endotoxemia. Inflamm Res 2005;54:464-70
18. Netea MG, de Bont N, Demacker PN, Kullberg BJ, Jacobs LE, Verver-Jansen TJ, Stalenhoef AF, Van der Meer JW. Lipoprotein(a) inhibits lipopolysaccharide- induced tumor necrosis factor α production by human mononuclear cells. Infect Immun 1998;66:2365-7
19. Pajkrt D, Doran JE, Koster F, Lerch PG, Arnet B, van der Poll T, ten Cate JW, van Deventer SJ. Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia. J Exp Med 1996;184:1601-8
20. Park KH, Yang HB, Kim HG, Lee YR, Hur H, Kim JS, Koo BS, Han MK, Kim JH, Jeong YJ, Kim JS. Low density lipoprotein inactivates Vibrio vulnificus cytolysin through the oligomerization of toxin monomer. Med Microbiol Immunol 2005;194:137-41
21. Parker TS, Levine DM, Chang JC, Laxer J, Coffin CC, Rubin AL. Reconstituted high-density lipoprotein neutralizes gram-negative bacterial lipopolysaccharides in human whole blood. Infect Immun 1995;63:253-8
22. Pussinen PJ, Metso J, Malle E, Barlage S, Palosuo T, Sattler W, Schmitz G, Jauhiainen M. The role of plasma phospholipid transfer protein (PLTP) in HDL remodeling in acute-phase patients. Biochim Biophys Acta 2001;1533:153-63
23. van Leeuwen HJ, Heezius EC, Dallinga GM, van Strijp JA, Verhoef J, van Kessel KP. Lipoprotein metabolism in patients with severe sepsis. Crit Care Med 2003;31:1359-66
24. Vanttinen M, Nuutila P, Kuulasmaa T, Pihlajamaki J, Hallsten K, Virtanen KA, Lautamaki R, Peltoniemi P, Takala T, Viljanen AP, Knuuti J, Laakso M. Single nucleotide polymorphisms in the peroxisome proliferator-activated receptor δ gene are associated with skeletal muscle glucose uptake. Diabetes 2005;54:3587-91
25. Vermont CL, den Brinker M, Kakeci N, de Kleijn ED, de Rijke YB, Joosten KF, de Groot R, Hazelzet JA. Serum lipids and disease severity in children with severe meningococcal sepsis. Crit Care Med 2005;33:1610-5
26. Wright AC, Morris JG, Jr. The extracellular cytolysin of Vibrio vulnificus: inactivation and relationship to virulence in mice. Infect Immun 1991;59:192-7
27. Wu A, Hinds CJ, Thiemermann C. High-density lipoproteins in sepsis and septic shock: metabolism, actions, and therapeutic applications. Shock 2004;21:210-21